{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:49:13Z","timestamp":1767134953095,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd007783","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2010,12,8]],"date-time":"2010-12-08T00:00:00Z","timestamp":1291766400000}}],"reference-count":20,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007783.pub2","type":"journal-article","created":{"date-parts":[[2010,11,29]],"date-time":"2010-11-29T14:53:40Z","timestamp":1291042420000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lamotrigine adjunctive therapy for refractory generalized tonic-clonic seizures"],"prefix":"10.1002","author":[{"given":"Eugene","family":"Tjia-Leong","sequence":"first","affiliation":[{"name":"Aintree University Hospital NHS Foundation Trust; Longmoor Lane Liverpool UK L9 7AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Leong","sequence":"additional","affiliation":[{"name":"Nottingham University Hospitals; Queens Medical Centre Derby Road Nottingham UK NG7 2UH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony G","family":"Marson","sequence":"additional","affiliation":[{"name":"Clinical Sciences Centre for Research & Education; University Department of Neurological Science; Lower Lane Fazakerley Liverpool Merseyside UK L9 7LJ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,12,8]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD007783.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1528-1157.1998.tb01332.x","article-title":"Double-blind placebo-controlled, crossover study of lamotringine in treatment-resistant generalised epilepsy","volume":"39","author":"Beran","year":"1998","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD007783.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1212\/01.wnl.0000187118.19221.e4","article-title":"Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures","volume":"65","author":"Biton","year":"2005","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD007783.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1542\/peds.2006-0148","article-title":"Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures","volume":"118","author":"Trevathan","year":"2006","journal-title":"Paediatrics"},{"issue":"5","key":"10.1002\/14651858.CD007783.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1528-1157.1998.tb01411.x","article-title":"The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: A randomized, double-blind, crossover study","volume":"39","author":"Eriksson","year":"1998","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD007783.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome","volume":"337","author":"Motte","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007783.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0920-1211(90)90077-9","article-title":"A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy","volume":"6","author":"Sander","year":"1990","journal-title":"Epilepsy Research"},{"issue":"S4","key":"10.1002\/14651858.CD007783.pub2-BIB0007|cit7","first-page":"47","article-title":"Evaluation of lamotrigine adjunctive therapy for primary generalized tonic-clonic seizures in patients with a history of absence epilepsy","volume":"47","author":"Tabbaa","year":"2006","journal-title":"Epilepsia"},{"issue":"8968","key":"10.1002\/14651858.CD007783.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0140-6736(95)91208-8","article-title":"Remission of epilepsy: results from the National General Practice Study of Epilepsy","volume":"346","author":"Cockerell","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007783.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/00003495-199550040-00008","article-title":"Lamotrigine: An update of its pharmacotherapy and therapeutic use in epilepsy","volume":"50","author":"Fitton","year":"1995","journal-title":"Drugs"},{"issue":"3","key":"10.1002\/14651858.CD007783.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1684\/j.1950-6945.1999.tb00315.x","article-title":"Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study","volume":"1","author":"Gericke","year":"1999","journal-title":"Epileptic Disorders"},{"issue":"3","key":"10.1002\/14651858.CD007783.pub2-BIB0011|cit11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003277.pub2","article-title":"Treatment of Lennox-Gastaut syndrome","author":"Hancock","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007783.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Commission on Classification and Terminology of the International League Against Epilepsy","volume":"30","author":"Anonymous","year":"1989","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD007783.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports or randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD007783.pub2-BIB0014|cit14","article-title":"Lamotrigine","volume-title":"Mechanisms of action in antiepileptic drugs","author":"Leach","year":"1995"},{"key":"10.1002\/14651858.CD007783.pub2-BIB0015|cit15","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated September 2009). The Cochrane Collaboration, 2009. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD007783.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD007783.pub2-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003032.pub2","article-title":"Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents","author":"Posner","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD007783.pub2-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001909","article-title":"Lamotrigine add-on for drug resistant partial epilepsy","author":"Ramaratnam","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD007783.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/jnnp.61.5.433","article-title":"Epidemiology of the epilepsies","volume":"61","author":"Sander","year":"1996","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD007783.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/archneur.62.9.1432","article-title":"Effect of antiepileptic drug co-medication on lamotrigine clearance","volume":"62","author":"Weintraub","year":"2005","journal-title":"Archives of Neurology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007783.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007783.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T11:59:11Z","timestamp":1711972751000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007783.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,12,8]]},"references-count":20,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007783.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,8]]}}}